Paulus Stoffels Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paulus Stoffels.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paulus Stoffels. Paulus Stoffels is Chief Scientific Officer in JOHNSON & JOHNSON ($JNJ) and Exec VP, Chief Scientific Off in JOHNSON & JOHNSON ($JNJ) and Vice Chair, Exec Committee in JOHNSON & JOHNSON ($JNJ).
Latest Insider Trading Transactions of Paulus Stoffels
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | M | 0.00 | 5,610 | 0 | 0 | |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | M | 0.00 | 29,452 | 0 | 0 | |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Payment of Exercise | F | 165.55 | 12,725 | 2,106,624 | 275,547 | 288.3 K to 275.5 K (-4.41 %) |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Payment of Exercise | F | 165.55 | 1,592 | 263,556 | 288,272 | 289.9 K to 288.3 K (-0.55 %) |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Buy | M | 0.00 | 5,610 | 0 | 289,864 | 284.3 K to 289.9 K (+1.97 %) |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Buy | M | 0.00 | 29,452 | 0 | 284,254 | 254.8 K to 284.3 K (+11.56 %) |
| Feb 10 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 0.00 | 5,605 | 0 | 5,605 | |
| Feb 10 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 0.00 | 29,452 | 0 | 29,452 | |
| Feb 10 2021 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 164.62 | 123,118 | 20,267,685 | 123,118 | |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | M | 0.00 | 11,695 | 0 | 0 | |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | M | 0.00 | 27,686 | 0 | 0 | |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Payment of Exercise | F | 150.46 | 12,022 | 1,808,830 | 254,799 | 266.8 K to 254.8 K (-4.51 %) |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Payment of Exercise | F | 150.46 | 4,079 | 613,726 | 266,821 | 270.9 K to 266.8 K (-1.51 %) |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Buy | M | 0.00 | 11,695 | 0 | 270,900 | 259.2 K to 270.9 K (+4.51 %) |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Buy | M | 0.00 | 27,686 | 0 | 259,205 | 231.5 K to 259.2 K (+11.96 %) |
| Feb 12 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 0.00 | 5,241 | 0 | 5,241 | |
| Feb 12 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 0.00 | 27,686 | 0 | 27,686 | |
| Feb 12 2020 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 151.41 | 134,064 | 20,298,630 | 134,064 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 0.00 | 5,606 | 0 | 5,606 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | M | 0.00 | 31,428 | 0 | 0 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | A | 131.94 | 114,575 | 15,117,026 | 114,575 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Option Exercise | M | 0.00 | 12,571 | 0 | 0 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Payment of Exercise | F | 131.94 | 15,884 | 2,095,735 | 231,516 | 247.4 K to 231.5 K (-6.42 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Grant | A | 0.00 | 5,154 | 0 | 247,400 | 242.2 K to 247.4 K (+2.13 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Buy | M | 0.00 | 31,428 | 0 | 242,246 | 210.8 K to 242.2 K (+14.91 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Payment of Exercise | F | 132.00 | 4,320 | 570,240 | 210,818 | 215.1 K to 210.8 K (-2.01 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Vice Chair, Exec Co ... | Buy | M | 0.00 | 12,571 | 0 | 215,138 | 202.6 K to 215.1 K (+6.21 %) |
| Feb 20 2018 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | M | 90.44 | 155,342 | 14,049,130 | 0 | |
| Feb 20 2018 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Sell | S | 129.86 | 155,342 | 20,172,401 | 202,564 | 357.9 K to 202.6 K (-43.40 %) |
| Feb 20 2018 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Buy | M | 90.44 | 155,342 | 14,049,130 | 357,906 | 202.6 K to 357.9 K (+76.69 %) |
| Feb 13 2018 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | M | 0.00 | 13,252 | 0 | 0 | |
| Feb 13 2018 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Payment of Exercise | F | 128.18 | 4,584 | 587,577 | 177,071 | 181.7 K to 177.1 K (-2.52 %) |
| Feb 13 2018 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Buy | M | 0.00 | 13,252 | 0 | 181,655 | 168.4 K to 181.7 K (+7.87 %) |
| Nov 02 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | M | 0.00 | 75,492 | 0 | 0 | |
| Nov 02 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Payment of Exercise | F | 139.54 | 34,742 | 4,847,899 | 168,400 | 203.1 K to 168.4 K (-17.10 %) |
| Nov 02 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Buy | M | 0.00 | 75,492 | 0 | 203,142 | 127.7 K to 203.1 K (+59.14 %) |
| Jul 26 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | M | 72.54 | 102,692 | 7,449,278 | 0 | |
| Jul 26 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Sell | S | 133.14 | 102,692 | 13,672,629 | 127,650 | 230.3 K to 127.7 K (-44.58 %) |
| Jul 26 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Buy | M | 72.54 | 102,692 | 7,449,278 | 230,342 | 127.7 K to 230.3 K (+80.45 %) |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Sell | S | 117.29 | 22,000 | 2,580,274 | 127,650 | 149.7 K to 127.7 K (-14.70 %) |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | A | 0.00 | 11,695 | 0 | 11,695 | |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | M | 0.00 | 26,447 | 0 | 0 | |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Option Exercise | A | 115.67 | 138,982 | 16,076,048 | 138,982 | |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Payment of Exercise | F | 115.67 | 17,027 | 1,969,513 | 149,650 | 166.7 K to 149.7 K (-10.22 %) |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Grant | A | 0.00 | 10,552 | 0 | 166,677 | 156.1 K to 166.7 K (+6.76 %) |
| Feb 16 2017 | JNJ | JOHNSON & JOHNSON | Stoffels Paulus | Exec VP, Chief Scie ... | Buy | M | 0.00 | 26,447 | 0 | 156,125 | 129.7 K to 156.1 K (+20.39 %) |
| Feb 19 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 72.54 | 125,000 | 9,067,500 | 102,692 | |
| Feb 19 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Sell | S | 102.43 | 125,000 | 12,803,250 | 122,543 | 247.5 K to 122.5 K (-50.50 %) |
| Feb 19 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 72.54 | 125,000 | 9,067,500 | 247,543 | 122.5 K to 247.5 K (+102.01 %) |
| Feb 10 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | A | 0.00 | 12,571 | 0 | 12,571 | |
| Feb 10 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 0.00 | 28,242 | 0 | 0 | |
| Feb 10 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | A | 101.87 | 174,787 | 17,805,552 | 174,787 | |
| Feb 10 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Payment of Exercise | F | 101.87 | 16,779 | 1,709,277 | 122,543 | 139.3 K to 122.5 K (-12.04 %) |
| Feb 10 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Grant | A | 0.00 | 8,218 | 0 | 139,322 | 131.1 K to 139.3 K (+6.27 %) |
| Feb 10 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 0.00 | 28,242 | 0 | 131,104 | 102.9 K to 131.1 K (+27.46 %) |
| Jan 20 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 0.00 | 11,297 | 0 | 0 | |
| Jan 20 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Payment of Exercise | F | 97.12 | 3,723 | 361,578 | 102,862 | 106.6 K to 102.9 K (-3.49 %) |
| Jan 20 2016 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 0.00 | 11,297 | 0 | 106,585 | 95.3 K to 106.6 K (+11.86 %) |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 61.75 | 19,109 | 1,179,981 | 0 | |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 62.62 | 24,521 | 1,535,505 | 0 | |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 65.37 | 160,133 | 10,467,894 | 0 | |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 62.20 | 24,920 | 1,550,024 | 0 | |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Sell | S | 100.73 | 187,250 | 18,862,142 | 94,473 | 281.7 K to 94.5 K (-66.47 %) |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 61.75 | 19,109 | 1,179,981 | 281,723 | 262.6 K to 281.7 K (+7.28 %) |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 62.62 | 24,521 | 1,535,505 | 262,614 | 238.1 K to 262.6 K (+10.30 %) |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 62.20 | 24,920 | 1,550,024 | 238,093 | 213.2 K to 238.1 K (+11.69 %) |
| Apr 30 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 65.37 | 160,133 | 10,467,894 | 213,173 | 53 K to 213.2 K (+301.91 %) |
| Feb 11 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | A | 0.00 | 13,252 | 0 | 13,252 | |
| Feb 11 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 0.00 | 29,073 | 0 | 0 | |
| Feb 11 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | A | 100.06 | 170,668 | 17,077,040 | 170,668 | |
| Feb 11 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Payment of Exercise | F | 100.06 | 14,892 | 1,490,094 | 53,040 | 67.9 K to 53 K (-21.92 %) |
| Feb 11 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Grant | A | 0.00 | 3,285 | 0 | 67,932 | 64.6 K to 67.9 K (+5.08 %) |
| Feb 11 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 0.00 | 29,073 | 0 | 64,647 | 35.6 K to 64.6 K (+81.73 %) |
| Jan 21 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | M | 0.00 | 11,629 | 0 | 0 | |
| Jan 21 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Payment of Exercise | F | 103.32 | 3,965 | 409,664 | 35,574 | 39.5 K to 35.6 K (-10.03 %) |
| Jan 21 2015 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Buy | M | 0.00 | 11,629 | 0 | 39,539 | 27.9 K to 39.5 K (+41.67 %) |
| Nov 04 2014 | JNJ | JOHNSON & JOHN ... | Stoffels Paulus | Chief Scientific Of ... | Option Exercise | A | 0.00 | 75,492 | 0 | 75,492 |
Page: 1